M. Shechter, Magnesium and cardiovascular system, Magnes Res, vol.23, pp.60-72, 2010.

S. L. Volpe, Magnesium, the metabolic syndrome, insulin resistance, and type 2 diabetes mellitus, Crit Rev Food Sci Nutr, vol.48, pp.293-300, 2008.

D. Kolte, K. Vijayaraghavan, S. Khera, D. A. Sica, and W. H. Frishman, Role of magnesium in cardiovascular diseases, Cardiol Rev, vol.22, pp.182-192, 2014.

M. J. Bolland, A. Grey, A. Avenell, G. D. Gamble, and I. R. Reid, Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis, BMJ, vol.342, p.2040, 2011.

S. Burgess and S. G. Thompson, Mendelian Randomization: Methods for Using Genetic Variants in Causal Estimation, 2015.

I. R. Reid, G. D. Gamble, and M. J. Bolland, Circulating calcium concentrations, vascular disease and mortality: a systematic review, J Intern Med, vol.279, pp.524-540, 2016.

S. M. Bristow, G. D. Gamble, and A. Stewart, Acute and 3-month effects of microcrystalline hydroxyapatite, calcium citrate and calcium carbonate on serum calcium and markers of bone turnover: a randomised controlled trial in postmenopausal women, Br J Nutr, vol.112, pp.1611-1620, 2014.

S. M. Bristow, G. D. Gamble, A. Stewart, R. Kalluru, A. M. Horne et al., Acute effects of calcium citrate with or without a meal, calcium-fortified juice and a dairy product meal on serum calcium and phosphate: a randomised cross-over trial, Br J Nutr, vol.113, pp.1585-1594, 2015.

X. Zhang, D. Gobbo, L. C. Hruby, and A. , The circulating concentration and 24-h urine excretion of magnesium dose-and time-dependently respond to oral magnesium supplementation in a meta-analysis of randomized controlled trials, J Nutr, vol.146, pp.595-602, 2016.

X. Zhang, J. Xia, D. Gobbo, L. C. Hruby, A. Dai et al., Serum magnesium concentrations and all-cause, cardiovascular, and cancer mortality among U.S. adults: results from the NHANES I Epidemiologic Follow-up Study, Clin Nutr, vol.37, pp.1541-1549, 2018.

T. Ohira, J. M. Peacock, H. Iso, L. E. Chambless, W. D. Rosamond et al., Serum and dietary magnesium and risk of ischemic stroke: the Atherosclerosis Risk in Communities Study, Am J Epidemiol, vol.169, pp.1437-1444, 2009.

S. N. Adebamowo, M. C. Jimenez, S. E. Chiuve, D. Spiegelman, W. C. Willett et al., Plasma magnesium and risk of ischemic stroke among women, Stroke, vol.45, pp.2881-2886, 2014.

R. N. Foley, A. J. Collins, A. Ishani, and P. A. Kalra, Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) Study, Am Heart J, vol.156, pp.556-563, 2008.

S. Rohrmann, H. Garmo, and H. Malmstrom, Association between serum calcium concentration and risk of incident and fatal cardiovascular disease in the prospective AMORIS study, Atherosclerosis, vol.251, pp.85-93, 2016.

G. D. Smith and S. Ebrahim, Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?, Int J Epidemiol, vol.32, pp.1-22, 2003.

S. C. Larsson, S. Burgess, and K. Michaëlsson, Serum magnesium levels and risk of coronary artery disease: mendelian randomisation study, BMC Med, vol.16, p.68, 2018.

S. C. Larsson, S. Burgess, and K. Michaelsson, Association of genetic variants related to serum calcium levels with coronary artery disease and myocardial infarction, JAMA, vol.318, pp.371-380, 2017.

T. E. Meyer, G. C. Verwoert, and S. J. Hwang, Genome-wide association studies of serum magnesium, potassium, and sodium concentrations identify six loci influencing serum magnesium levels, PLoS Genet, vol.6, p.1001045, 2010.

C. M. O'seaghdha, H. Wu, and Q. Yang, Meta-analysis of genome-wide association studies identifies six new loci for serum calcium concentrations, PLoS Genet, vol.9, p.1003796, 2013.

R. Malik, G. Chauhan, and M. Traylor, Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes, Nat Genet, vol.50, pp.524-537, 2018.

H. P. Adams, B. H. Bendixen, and L. J. Kappelle, Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment, Stroke, vol.24, pp.35-41, 1993.

S. Burgess, J. Bowden, T. Fall, E. Ingelsson, and S. G. Thompson, Sensitivity analyses for robust causal inference from mendelian randomization analyses with multiple genetic variants, Epidemiology, vol.28, pp.30-42, 2017.

S. Burgess, V. Zuber, A. Gkatzionis, and C. N. Foley, Modal-based estimation via heterogeneity-penalized weighting: model averaging for consistent and efficient estimation in mendelian randomization when a plurality of candidate instruments are valid, Int J Epidemiol, vol.47, pp.1242-1254, 2018.

S. Burgess and S. G. Thompson, Interpreting findings from mendelian randomization using the MR-Egger method, Eur J Epidemiol, vol.32, pp.377-389, 2017.

J. Bowden, D. Greco, M. F. Minelli, C. , D. Smith et al., Assessing the suitability of summary data for two-sample mendelian randomization analyses using MR-Egger regression: the role of the I 2 statistic, Int J Epidemiol, vol.45, pp.1961-1974, 2016.

M. Verbanck, C. Y. Chen, N. B. Do, and R. , Detection of widespread horizontal pleiotropy in causal relationships inferred from mendelian randomization between complex traits and diseases, Nat Genet, vol.50, pp.693-698, 2018.

, Available at: CRAN.R-project.org/package=MendelianRandomization, 2018.

M. J. Brion, K. Shakhbazov, and P. M. Visscher, Calculating statistical power in mendelian randomization studies, Int J Epidemiol, vol.42, pp.1497-1501, 2013.

S. C. Larsson, N. Orsini, and A. Wolk, Dietary magnesium intake and risk of stroke: a metaanalysis of prospective studies, Am J Clin Nutr, vol.95, pp.362-366, 2012.

A. M. Khan, S. A. Lubitz, and L. M. Sullivan, Low serum magnesium and the development of atrial fibrillation in the community: the Framingham Heart Study, Circulation, vol.127, pp.33-38, 2013.

J. R. Misialek, F. L. Lopez, and P. L. Lutsey, Serum and dietary magnesium and incidence of atrial fibrillation in whites and in African Americans: Atherosclerosis Risk in Communities (ARIC) study, Circ J, vol.77, pp.323-329, 2013.

C. Roselli, M. D. Chaffin, and L. C. Weng, Multi-ethnic genome-wide association study for atrial fibrillation, Nat Genet, vol.50, pp.1225-1233, 2018.

R. Kh, M. Khullar, M. Kashyap, P. Pandhi, and R. Uppal, Effect of oral magnesium supplementation on blood pressure, platelet aggregation and calcium handling in deoxycorticosterone acetate induced hypertension in rats, J Hypertens, vol.18, pp.919-926, 2000.

M. Shechter, C. N. Merz, and M. Paul-labrador, Oral magnesium supplementation inhibits platelet-dependent thrombosis in patients with coronary artery disease, Am J Cardiol, vol.84, pp.152-156, 1999.

J. F. Dong, M. A. Cruz, and K. Aboulfatova, Magnesium maintains endothelial integrity, up-regulates proteolysis of ultra-large von Willebrand factor, and reduces platelet aggregation under flow conditions, Thromb Haemost, vol.99, pp.586-593, 2008.

A. R. Cunha, D. El-rei, J. Medeiros, and F. , Oral magnesium supplementation improves endothelial function and attenuates subclinical atherosclerosis in thiazide-treated hypertensive women, J Hypertens, vol.35, pp.89-97, 2017.

M. Shechter, M. Sharir, M. J. Labrador, J. Forrester, B. Silver et al., Oral magnesium therapy improves endothelial function in patients with coronary artery disease, Circulation, vol.102, pp.2353-2358, 2000.

H. Verma and R. Garg, Effect of magnesium supplementation on type 2 diabetes associated cardiovascular risk factors: a systematic review and meta-analysis, J Hum Nutr Diet, vol.30, pp.621-633, 2017.

A. Hruby, C. J. Donnell, P. F. Jacques, J. B. Meigs, U. Hoffmann et al., Magnesium intake is inversely associated with coronary artery calcification: the Framingham Heart Study, JACC Cardiovasc Imaging, vol.7, pp.59-69, 2014.

P. J. Joris, J. Plat, S. J. Bakker, and R. P. Mensink, Long-term magnesium supplementation improves arterial stiffness in overweight and obese adults: results of a randomized, double-blind, placebo-controlled intervention trial, Am J Clin Nutr, vol.103, pp.1260-1266, 2016.

J. B. Morais, J. S. Severo, and L. R. Santos, Role of magnesium in oxidative stress in individuals with obesity, Biol Trace Elem Res, vol.176, pp.20-26, 2017.

L. E. Simental-mendia, A. Sahebkar, M. Rodriguez-moran, and F. Guerrero-romero, A systematic review and meta-analysis of randomized controlled trials on the effects of magnesium supplementation on insulin sensitivity and glucose control, Pharmacol Res, vol.111, pp.272-282, 2016.

S. C. Larsson and A. Wolk, Magnesium intake and risk of type 2 diabetes: a meta-analysis, J Intern Med, vol.262, pp.208-214, 2007.

J. Wu, P. Xun, Q. Tang, W. Cai, and K. He, Circulating magnesium levels and incidence of coronary heart diseases, hypertension, and type 2 diabetes mellitus: a meta-analysis of prospective cohort studies, Nutr J, vol.16, p.60, 2017.